Presentations & Publications

Presentation

Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity

AACR 2018

Publication

Neoantigens that fail to elicit measurable T cell responses following peptide immunization can control tumor growth when delivered using a Listeria-based immunotherapy platform

AACR 2018

Presentation

Targeting frameshift mutations with a Listeria monocytogenes immunotherapy drives neoantigen-specific anti-tumor immunity in the MC38 and CT26 mouse tumor models

AACR 2018

Presentation

Targeting of CCR8 induces antitumor activity as a monotherapy that is further enhanced in combination with a Listeria-based immunotherapy

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Presentation

Combination TIGIT blockade with Listeria-based immunotherapy enhances antigen-specific antitumor immunity

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Presentation

Agonism of the CD137 co-stimulatory pathway synergizes with the Listeria monocytogenes-based immunotherapy, axalimogene filolisbac, to promote durable tumor regression in a murine HPV+ tumor model

2018 Keystone Symposia on Cancer Immunotherapies: Combinations, March 25, 2018

Presentation

Advaxis’ Listeria monocytogenes-based immunotherapies rapidly impair intratumoral regulatory T cell survival and function and promote effector T cell recruitment, activation and differentiation

SITC, November 13, 2017

Presentation

2017 Investor Analyst Day

June 12, 2017

Presentation

High-dose treatment with ADXS11-001, a Listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer

SGO, March 27, 2017

Presentation

AACR 2015 Reception Presentation with Late Breaking Poster

AACR, April 19, 2015

Publication

Listeria vaccines join the checkpoint frenzy.

Published in Nat Biotechnol, December 2014

Publication

Lm-LLO Immunotherapies Targeting Multiple Antigens and Their Impact on Different Mechanisms in the Tumor Microenvironment

SITC, November 10, 2014

Publication

Listeria monocytogenes (Lm)-LLO Immunotherapies Reduce the Immunosuppressive Activity of Myeloid-derived Suppressor Cells and Regulatory T Cells in the Tumor Microenvironment

Published in the Journal of Immunotherapy, November 2013

Publication

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

Published in the Journal for ImmunoTherapy of Cancer, August 29, 2013

Publication

Listeria monocytogenes-Derived Listeriolysin O Has Pathogen Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability

Published in Clinical and Vaccine Immunology, January 2013